IL113992A0 - Use of copolymer-1 - Google Patents

Use of copolymer-1

Info

Publication number
IL113992A0
IL113992A0 IL11399295A IL11399295A IL113992A0 IL 113992 A0 IL113992 A0 IL 113992A0 IL 11399295 A IL11399295 A IL 11399295A IL 11399295 A IL11399295 A IL 11399295A IL 113992 A0 IL113992 A0 IL 113992A0
Authority
IL
Israel
Prior art keywords
copolymer
Prior art date
Application number
IL11399295A
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL113992A0 publication Critical patent/IL113992A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11399295A 1994-06-06 1995-06-02 Use of copolymer-1 IL113992A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9411292A GB9411292D0 (en) 1994-06-06 1994-06-06 Pharmaceuticals compositions

Publications (1)

Publication Number Publication Date
IL113992A0 true IL113992A0 (en) 1995-10-31

Family

ID=10756253

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11399295A IL113992A0 (en) 1994-06-06 1995-06-02 Use of copolymer-1

Country Status (8)

Country Link
EP (1) EP0767672A1 (en)
JP (1) JPH10500695A (en)
AU (1) AU2787495A (en)
CA (1) CA2192218A1 (en)
GB (1) GB9411292D0 (en)
IL (1) IL113992A0 (en)
WO (1) WO1995033475A1 (en)
ZA (1) ZA954469B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214791B1 (en) 1997-01-10 2001-04-10 Yeda Research And Development Co. Ltd. Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
ES2527760T3 (en) 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Treatment of Crohn's disease with copolymer 1 and polypeptides
WO2000005250A1 (en) 1998-07-23 2000-02-03 Yeda Research And Development Co., Ltd Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
ZA200206457B (en) 2000-02-18 2003-08-13 Yeda Res & Dev Oral, nasal and pulmonary dosage formulations of copolymer 1.
US20020077278A1 (en) 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
AU7528001A (en) * 2000-06-05 2001-12-17 Teva Pharma The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (en) 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Treatment of central nervous system diseases by antibodies against glatiramer acetate
IL148202A0 (en) * 2000-06-20 2002-09-12 Caprion Pharmaceuticals Inc Copolymers and methods of treating prion-related diseases
SI1459065T1 (en) 2001-12-04 2010-11-30 Teva Pharma Processes for the measurement of the potency of glatiramer acetate
JP5297653B2 (en) 2004-10-29 2013-09-25 サンド・アクチエンゲゼルシヤフト Manufacturing method of glatiramer

Also Published As

Publication number Publication date
AU2787495A (en) 1996-01-04
WO1995033475A1 (en) 1995-12-14
EP0767672A1 (en) 1997-04-16
GB9411292D0 (en) 1994-07-27
JPH10500695A (en) 1998-01-20
ZA954469B (en) 1996-01-24
CA2192218A1 (en) 1995-12-14

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
GB9526560D0 (en) Use of 2-Amino-Heterocycles
EP0785806A4 (en) Single use syringe
ZA9684B (en) Composition and use
GB9501560D0 (en) Contrast agents
ZA951232B (en) Contrast agents
ZA957113B (en) Use of N-substituted pyhenothiazines
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
IL113992A0 (en) Use of copolymer-1
ZA959517B (en) Leutherobin and analogs thereof
HU9700071D0 (en) Use of muramilpeptides
GB9414157D0 (en) Medical use
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
GB9411045D0 (en) Compounds and use
HUP9901448A3 (en) Novel medical use
GB9508637D0 (en) New use
ZA9510848B (en) Mutable composition
ZA963484B (en) New use
GB9512703D0 (en) Composition and use
IL117844A0 (en) Use of (s)-adenosyl-l-methionine
GB9516136D0 (en) New Use
GB9520119D0 (en) Use
GB9505071D0 (en) Use
GB9519905D0 (en) Use
GB9519915D0 (en) Use